אטוסיבן - פרינג

국가: 이스라엘

언어: 히브리어

출처: Ministry of Health

유효 성분:

ATOSIBAN

제공처:

FERRING PHARMACEUTICALS LTD

ATC 코드:

G02CX01

약제 형태:

SOLUTION FOR INJECTION

구성:

ATOSIBAN 7.5 MG/ML

관리 경로:

תוך-ורידי

처방전 유형:

מרשם נדרש

Manufactured by:

FERRING GmbH ,GERMANY

치료 그룹:

ATOSIBAN

치료 영역:

ATOSIBAN

치료 징후:

Atosiban is indicated to delay imminent pre-term birth in pregnant women with: - regular uterine contractions of at least 30 seconds duration at a rate of 4 or more per 30 minutes - a cervical dilation of 1 to 3 cm (0-3 for iparas) and effacement of 50 % or more - age: 18 years and above - a gestational age from 24 until 33 completed weeks - a normal foetal heart rate.

승인 날짜:

2015-08-31